Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease. A Phase II Randomized, Double-Blind, Controlled Study of Adenoviral Delivery of Vascular Endothelial Growth factor 121 in patients With Disabling Intermittent Claudication.